Genetic research
Development of a Novel Safety Assessment Method for mRNA Vaccines Based on Lung Biomarker Gene Expression
Researchers from the National Institute of Infectious Diseases in Japan have developed a new safety assessment method for mRNA vaccines based on lung biomarker gene expression. The study, published in the journal Vaccine, examined the bioactivity and toxicity profiles of SARS-CoV-2 mRNA vaccines, including Spikevax and COMIRNATY. The researchers found